
CAS Number125-04-2
SynonymsSodium 4-{[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoate; Solu-Glyc; Butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl] ester, sodium salt (1:1); Hydrocortisone hemisuccinate sodium salt; Intracort; Hydrocortisone sodium succinate; MFCD00069472; (11b)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxypregn-4-ene-3,20-dione Monosodium Salt; Saxizon; EINECS 204-725-5; Buccalsone; butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl] ester, monosodium salt; Hydrocortisone 21-sodium succinate; Corlan; Nordicort; Sodium 17-hydroxycorticosterone 21-succinate
Molecular FormulaC25H33NaO8
Molecular Weight484.51
Purity≥90 (HPLC)%
Boiling Point685.5ºC at 760mmHg
Appearancepowder
EINECS204-725-5
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 125-04-2 |
| Catalog No. | 2A-9020541 |
| Chinese Name | 氢化可的松琥珀酸钠 |
| Synonyms | Sodium 4-{[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoate; Solu-Glyc; Butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl] ester, sodium salt (1:1); Hydrocortisone hemisuccinate sodium salt; Intracort; Hydrocortisone sodium succinate; MFCD00069472; (11b)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxypregn-4-ene-3,20-dione Monosodium Salt; Saxizon; EINECS 204-725-5; Buccalsone; butanedioic acid, mono[(11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl] ester, monosodium salt; Hydrocortisone 21-sodium succinate; Corlan; Nordicort; Sodium 17-hydroxycorticosterone 21-succinate |
| Molecular Formula | C25H33NaO8 |
| Molecular Weight | 484.51 |
| Purity | ≥90 (HPLC) |
| Boiling Point | 685.5ºC at 760mmHg |
| Appearance | powder |
| Water Solubility | H2O: 50 mg/mL |
| Storage Condition | −20℃。 |
| Application | Hydrocortisone hemisuccinate sodium is an orally active physiological glucocorticoid. Hydrocortisone hemisuccinate sodium inhibits the biological activities of IL-6 and IL-3 with IC50 values of 6.7 |
| EINECS | 204-725-5 |
| PubChem ID | 24278463 |
| MDL Number | MFCD00069472 |
| SMILES | O=C1CC[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(O)C(COC(CCC([O-])=O)=O)=O)=C1.[Na+] |
| InChI | 1S/C25H34O8.Na/c1-23-9-7-15(26)11-14(23)3-4-16-17-8-10-25(32,24(17,2)12-18(27)22(16)23)19(28)13-33-21(31)6-5-20(29)30;/h11,16-18,22,27,32H,3-10,12-13H2,1-2H3,(H,29,30);/q;+1/p-1/t16-,17-,18-,22+,23-,24-,25-;/m0./s1 |
| InChI Key | HHZQLQREDATOBM-CODXZCKSSA-M |
| NACRES Code | NA.77 |
| UNSPSC | 12352209 |
| MSDS | msds/20541_1_125_04_2.pdf |
| Bioactivity | Hydrocortisone hemisuccinate sodium is an orally active physiological glucocorticoid. Hydrocortisone hemisuccinate sodium inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone hemisuccinate sodium can be used for the research of ulcerative colitis (UC)[1]. Related Catalog Research Areas >> Metabolic Disease Signaling Pathways >> GPCR/G Protein >> Glucocorticoid Receptor In Vitro Hydrocortisone hemisuccinate sodium inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells[3]. Hydrocortisone hemisuccinate sodium (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures[3]. In Vivo Hydrocortisone hemisuccinate sodium (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice[2]. Animal Model: Male Sprague-Dawley rats (200-220 g, 10-11 weeks) are induced colitis[2] Dosage: 30 mg/kg Administration: P.o. twice daily for 5 days Result: Significantly decreased the disease activity index (DAI) scores and myeloperoxidase (MPO) activity compared to the 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) group. Increased the body weight. References [1]. Kang BS, et, al. Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity. Biol Pharm Bull. 2001 Jun;24(6):701-3. [2]. You YC, et, al. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy. Carbohydr Polym. 2015 Oct 5;130:243-53. [3]. Langhoff E, et, al. The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Int J Immunopharmacol. 1987;9(4):469-73. Chemical & Physical Properties Boiling Point 685.5ºC at 760mmHg Molecular Formula C25H33NaO8 Molecular Weight 484.51 Flash Point 231.1ºC Exact Mass 484.207306 PSA 141.03000 LogP 0.86260 Appearance of Characters powder Vapour Pressure 9.36E-22mmHg at 25°C InChIKey LGKJVUKNTHOZJH-CODXZCKSSA-N SMILES CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)COC(=O)CCC(=O)O.[Na] Storage condition −20°C Water Solubility H2O: 50 mg/mL |
| Use of | Hydrocortisone hemisuccinate sodium is an orally active physiological glucocorticoid. Hydrocortisone hemisuccinate sodium inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone hemisuccinate sodium can be used for the research of ulcerative colitis (UC)[1]. Properties Articles27 Name Hydrocortisone Hemisuccinate Sodium Salt Synonym More Synonyms Corlan Biological Activity Description Hydrocortisone hemisuccinate sodium is an orally active physiological glucocorticoid. Hydrocortisone hemisuccinate sodium inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone hemisuccinate sodium can be used for the research of ulcerative colitis (UC)[1]. Related Catalog Research Areas >> Metabolic Disease Signaling Pathways >> GPCR/G Protein >> Glucocorticoid Receptor References [1]. Kang BS, et, al. Inhibitory effects of anti-inflammatory drugs on interleukin-6 bioactivity. Biol Pharm Bull. 2001 Jun;24(6):701-3. [2]. You YC, et, al. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy. Carbohydr Polym. 2015 Oct 5;130:243-53. [3]. Langhoff E, et, al. The immunosuppressive potency in vitro of physiological and synthetic steroids on lymphocyte cultures. Int J Immunopharmacol. 1987;9(4):469-73. Chemical & Physical Properties Molecular Formula C25H33NaO8 Exact Mass 484.207306 PSA 141.03000 LogP 0.86260 Appearance of Characters powder InChIKey LGKJVUKNTHOZJH-CODXZCKSSA-N |
| Transport Info | Product Name: Hydrocortisone Sodium Succinate |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| Pyrazinamide | 98-96-4 | 2A-9018103 |
| Aztreonam | 78110-38-0 | 2A-9018504 |
| Hydroxychloroquine | 118-42-3 | 2A-9018997 |
| METHYLPREDNISOLONE SODIUM SUCCINATE | 2375-03-3 | 2A-9020531 |
| Triamcinolone | 124-94-7 | 2A-9020539 |
| Dihydrostreptomycin | 128-46-1 | 2A-9020610 |
| Thioridazine hydrochloride | 130-61-0 | 2A-9020654 |
| Chloroquine sulfate | 132-73-0 | 2A-9020693 |
| Betamethasone 21-phosphate disodium | 151-73-5 | 2A-9021018 |
| Lincomycin | 154-21-2 | 2A-9021035 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA